Attorney:
Sameer Gokhale
December 13, 2022
In the Federal Circuit decision in Amgen Inc. v. Sanofi[1], while invalidating two of Amgen’s antibody patents, the CAFC made the following statement regarding the enablement requirement of 35 U.S.C. §112.<... Read more
Attorney:
Sameer Gokhale
November 11, 2020
The USPTO recently released a report on public comments that were received in response to two requests for comments (RFCs) regarding artificial intelligence ("Public Views on Artificial Intelligence and Intellectual Property Policy"). The USPTO states that it will use this report to focus issues for continued exploration of other measures it may take to bolster the understanding and reliability of IP rights for emerging technologies, such as AI.... Read more